Safety and oncologic efficacy of robotic surgery compared to open surgery after neoadjuvant therapy for pancreatic cancer

Authors:

Abstract
Neoadjuvant therapy (NAT) has become the recommended treatment approach for patients with borderline resectable or locally advanced pancreatic cancer. Howe
Funding Information
  • CAMS Innovation Fund for Medical Sciences (2024-I2M-ZD-001)
  • the National High Level Hospital Clinical Research Funding (2022-PUMCH-B-004)
  • National Natural Science Foundation of China (82573271)

This publication has 25 references indexed in Scilit: